Table 1.
Patients’ demographic characteristics.
| Overall (n = 55) | PD (progressive disease, n = 18) | Non-PD (n = 37) | P-value | |
|---|---|---|---|---|
| Sex (%) | 0.160 | |||
| Female | 5 (9.1) | 0 (0.0) | 5 (13.5) | |
| Male | 50 (90.9) | 18 (100.0) | 32 (86.5) | |
| Age (median [interquartile range, IQR]) | 53.00 [43.00, 55.00] | 51.50 [48.50, 55.00] | 53.00 [43.00, 57.00] | 0.336 |
| Hepatitis B virus infection (%) | 0.247 | |||
| No | 3 (5.5) | 2 (11.1) | 1 (2.7) | |
| Yes | 52 (94.5) | 16 (88.9) | 36 (97.3) | |
| Platelets (median [IQR]) | 194.00 [162.50, 282.50] | 198.50 [160.50, 319.00] | 192.00 [164.00, 281.00] | 0.851 |
| Albumin-bilirubin (mean (standard deviation, SD)) | − 2.60 (0.44) | − 2.29 (0.38) | − 2.76 (0.38) | < 0.001 |
| Aspartate aminotransferase (median [IQR]) | 60.30 [36.90, 95.00] | 64.85 [40.17, 116.58] | 60.30 [36.90, 84.10] | 0.379 |
| Alanine transaminase (median [IQR]) | 44.50 [30.45, 66.30] | 48.75 [28.85, 71.20] | 40.90 [30.70, 66.00] | 0.713 |
| Alkaline phosphatase (median [IQR]) | 134.10 [102.90, 182.50] | 137.75 [101.62, 219.65] | 131.00 [106.60, 173.60] | 0.446 |
| Alpha fetoprotein level (%) | 0.761 | |||
| < 200 ng/ml | 18 (32.7) | 5 (27.8) | 13 (35.1) | |
| ≥ 200 ng/ml | 37 (67.3) | 13 (72.2) | 24 (64.9) | |
| Number (%) | > 0.99 | |||
| Single | 21 (38.2) | 7 (38.9) | 14 (37.8) | |
| Multiple | 34 (61.8) | 11 (61.1) | 23 (62.2) | |
| Diameter (%) | 0.713 | |||
| < 5 cm | 10 (18.2) | 4 (22.2) | 6 (16.2) | |
| ≥ 5 cm | 45 (81.8) | 14 (77.8) | 31 (83.8) | |
| Vascular invasion (%) | > 0.99 | |||
| No | 11 (20.0) | 3 (16.7) | 8 (21.6) | |
| Yes | 44 (80.0) | 15 (83.3) | 29 (78.4) | |
| Distant spread (%) | 0.764 | |||
| No | 36 (65.5) | 11 (61.1) | 25 (67.6) | |
| Yes | 19 (34.5) | 7 (38.9) | 12 (32.4) |